Thyroid remnant 131I ablation for papillary and follicular thyroid carcinoma

Thyroid

Volumn 7, Issue 2, 1997, Pages 265-271

  Mazzaferri, Ernest L ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CHILD; FEMALE; FOLLICULAR CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; THYROID CARCINOMA; TREATMENT OUTCOME; ADENOCARCINOMA; COHORT ANALYSIS; METASTASIS; MIDDLE AGED; MORTALITY; THYROID TUMOR; THYROIDECTOMY; TUMOR RECURRENCE;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; CARCINOMA, PAPILLARY; CHILD; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0030611976     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1997.7.265     Document Type: Article

References (29)

1. Mazzaferri EL, Jhiang SM 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428.
2. Hay ID 1990 Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 19:545-576.
3. Solomon BL, Wartofsky L, Burman KD 1996 Current trends in the management of well differentiated papillary thyroid carcinoma. J Clin Endocrinol Metab 81:333-339.
4. Van De Velde CJH, Hamming JF, Goslings BM, et al. 1988 Report of the consensus development conference on the management of differentiated thyroid cancer in the Netherlands. Eur J Cancer Clin Oncol 24:287-292.
5. Baldet L, Manderscheid JC, Glinoer D, Jaffiol C, Coste Seignovert B, Percheron C 1989 The management of differentiated thyroid cancer in Europe in 1988. Results of an international survey. Acta Endocrinol (Copenh) 120:547-558.
6. Mazzaferri EL 1996 Carcinoma of follicular epithelium: Radiodine and other treatment outcomes. In: Braverman LE, Utiger RD (eds) The thyroid: A fundamental and clinical text, 7th ed. Lippincott-Raven, Philadelphia, pp. 922-945.
7. Vassilopoulou-Sellin R, Klein MJ, Smith TH, et al. 1993 Pulmonary metastases in children and young adults with differentiated thyroid cancer. Cancer 71:1348-1352.
8. Ozata M, Suzuki S, Miyamoto T, Liu RT, Fierro-Renoy F, DeGroot LJ 1994 Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab 79:98-105.
9. Wong JB, Kaplan MM, Meyer KB, Pauker SG 1990 Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. A decision analytic perspective. Endocrinol Metab Clin North Am 19:741-760.
10. Mazzaferri EL, Young RL, Oertel JE, Kemmerer WT, Page CP 1977 Papillary thyroid carcinoma: The impact of therapy in 576 patients. Medicine (Baltimore) 56:171-196.
11. Mazzaferri EL. Impact of initial tumor features and treatment selected on the long-term course of differentiated thyroid cancer 1995 Thyroid Today 18:1-13.
12. Maxon H III, Smith HS 1990 Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinol Metab Clin North Am 19:685-718.
13. Snyder J, Gorman C, Scanion P 1983 Thyroid remnant ablation: Questionable pursuit of an ill-defined goal. J Nucl Med 24:659-665.
14. McConahey WM, Hay ID, Woolner LB, van Heerden JA, Taylor WF 1986 Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: Initial manifestations, pathologic findings, therapy and outcome. Mayo Clin Proc 61:978-996.
15. Dulgeroff AJ, Hershman JM 1994 Medical therapy for differentiated thyroid carcinoma. Endocrine Rev 15:500-515.
16. DeGroot LJ, Kaplan EL, McCormick M, Straus FH 1990 Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414-424.
17. Krishnamurthy GT, Blahd WH 1977 Radioiodine I-131 therapy in the management of thyroid cancer. A prospective study. Cancer 40:195-202.
18. Massin JP, Savoie JC, Gamier H, Guiraudon G, Leger FA, Bacourt F 1984 Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment. Cancer 53:982-992.
19. Simpson WJ, Panzarella T, Carruthers JS, Gospodarowicz MK, Sutcliffe SB 1988 Papillary and follicular thyroid can cer: Impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys 14:1063-1075.
20. McCowen KD, Adler RA, Ghaed N, Verdon T, Hofeldt FD 1976 Low dose radioiodine thyroid ablation in postsurgical patients with thyroid cancer. Am J Med 61:52-58.
21. DeGroot LJ, Reilly M 1982 Comparison of 30- and 50-mCi doses of iodine-131 for thyroid ablation. Ann Intern Med 96:51-53.
22. Beierwaltes WH, Rabbani R, Dmuchowski C, Lloyd RV, Eyre P, Mallette S 1984 An analysis of "ablation of thyroid remnants" with 1-131 in 511 patients from 1947-1984: Experience at University of Michigan. J Nucl Med 25:1287-1293.
23. Maxon HR, Englaro EE, Thomas SR, et al. 1992 Radioiodine-131 therapy for well-differentiated thyroid cancer - a quantitative radiation dosimetric approach: Outcome and validation in 85 patients. J Nucl Med 33:1132-1136.
24. Samuel AM, Rajashekharrao B 1994 Radioiodine therapy for well-differentiated thyroid cancer: A quantitative dosimetric evaluation for remnant thyroid ablation after surgery. J Nucl Med 35:1944-1950.
25. Kuni CC, Klingensmith WC 1980 Failure of low doses of 131-I to ablate residual thyroid tissue following surgery for thyroid cancer. Radiology 137:773-774.
26. Siddiqui AR, Edmondson J, Wellman HN, et al. 1981 Feasibility of low doses of I-131 for thyroid ablation in postsurgical patients with thyroid carcinoma. Clin Nucl Med 6:158-161.
27. Ramanna L, Waxman AD, Brachman MB, Tanasescu DE, Sensel N, Braunstein GD 1985 Evaluation of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients. Clin Nucl Med 10:791-795.
28. Johansen K, Woodhouse NJ, Odugbesan O 1991 Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer. J Nucl Med 32:252-254.
29. Pineda JD, Lee T, Ain K, Reynolds J, Robbins J 1995 Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Clin Endocrinol Metab 80:1488-1492.